BCL2 and neoplasm: An interesting finding was that the greatest inhibition in tumor development was with the VCR/EGCG group, significantly both VCR and EGCG and the combination presented an increase in p53 and a decrease in the expression of the antiapoptotic protein Bcl2, observing a more extensive decrease with concomitant treatment than with independent treatments.